QR Kodea

Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD)

<b>Background</b>: Cannabidiol (CBD) is an approved treatment for childhood epilepsies and a candidate treatment for several other CNS disorders. However, it has poor oral bioavailability. We investigated the effect of a novel lipid formulation on its absorption in humans and on its tissue distribut...

Deskribapen osoa

Gorde:
Egile Nagusiak: Edward Chesney, Ndabezinhle Mazibuko, Dominic Oliver, Amedeo Minichino, Ayşe Doğa Lamper, Lucy Chester, Thomas J. Reilly, Millie Lloyd, Matilda Kråkström, Alex M. Dickens, Matej Orešič, Eric Lynch, Gregory Stoloff, Mitul A. Mehta, Philip McGuire
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2024-12-01
Saila:Pharmaceutics
Gaiak:
CBD
cannabidiol
pharmacokinetics
bioavailability
formulation
Sarrera elektronikoa:https://www.mdpi.com/1999-4923/16/12/1537
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak